Table Of Contents:

1. Market Context & Strategic Relevance
 1.1 Opening Context (Why the market matters)
  1.1.1 Why This Market Is Gaining Strategic Attention
  1.1.2 Business Decisions This Report Supports
 1.2 Scope
 1.3 Research & Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
 2.3 Market Size & Forecast, By Segmentation, 2022–2035
  2.3.1 Market Size By Product
  2.3.2 Market Size By Application
  2.3.3 Market Size By Procedure Type
  2.3.4 Market Size By End-User
 2.4 Market Share & Bps Analysis By Region, 2025
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO's Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter's) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1. Component & Subsystem Suppliers
  3.4.2. Neurointerventional Device Manufacturers
  3.4.3. Distributors & Channel Partners
  3.4.4. End Users (Hospitals, Specialty Clinics, ASCs)
 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting
 4.1 Clinical Outcomes & Procedure Success Metrics
  4.1.1 Average Recanalization Rate (TICI 2b/3) Achieved with Neurointerventional Procedures (%)
  4.1.2 Percentage Reduction in Mortality Rate Following Endovascular Thrombectomy (%)
  4.1.3 Average Reduction in Post-Procedure Neurological Deficits (NIHSS Score Improvement)
  4.1.4 Percentage of Patients Achieving Functional Independence (mRS ≤ 2) Post-Intervention (%)
  4.1.5 Average Rate of Successful Aneurysm Occlusion Using Embolization Coils & Stents (%)
 4.2 Procedure & Operational Efficiency Indicators
  4.2.1 Average Reduction in Door-to-Puncture Time in Thrombectomy Procedures (Minutes)
  4.2.2 Average Number of Devices Used Per Neurointerventional Procedure
  4.2.3 Percentage Improvement in First-Pass Recanalization Rate with Advanced Stent Retrievers (%)
  4.2.4 Average Fluoroscopy Time Reduction with Next-Generation Imaging Integration (Minutes)
  4.2.5 Percentage of Neurointerventional Procedures Performed in Hybrid OR Settings (%)
 4.3 Device Adoption & Technology Penetration Metrics
  4.3.1 Share of Stent Retrievers vs. Aspiration Catheters in Mechanical Thrombectomy Procedures (%)
  4.3.2 Percentage Growth in Flow Diverter Adoption for Intracranial Aneurysm Treatment (%)
  4.3.3 Average Adoption Rate of Neurointerventional Devices in Emerging Markets (%)
  4.3.4 Percentage of Procedures Utilizing Radial Access vs. Femoral Access in Neurointervention (%)
  4.3.5 Share of Biodegradable vs. Permanent Neurovascular Stents in Clinical Use (%)
 4.4 Healthcare Economics & Patient Access Indicators
  4.4.1 Average Cost Savings Per Patient Through Improved Outcomes Post-Neurointervention (USD)
  4.4.2 Percentage Reduction in Long-Term Disability Costs Through Endovascular Treatment (%)
  4.4.3 Average Reduction in Hospital Length of Stay Post-Thrombectomy vs. Medical Management (Days)
  4.4.4 Percentage of Neurointerventional Procedures Covered by Reimbursement in Major Markets (%)
  4.4.5 Average Increase in Patient Access to Neurointerventional Care in Stroke Networks (%)

5. Neurointerventional Devices Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)
 5.1 Introduction
 5.2 Embolization Coils
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Stent Retrievers
 5.4 Neurovascular Stents
 5.5 Microcatheters & Guidewires
 5.6 Balloon Systems
 5.7 Others

6. Neurointerventional Devices Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
 6.1 Introduction
 6.2 Ischemic Stroke
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022–2035
 6.3 Intracranial Aneurysm
 6.4 Arteriovenous Malformation (AVM)
 6.5 Cerebral Hemorrhage
 6.6 Others

7. Neurointerventional Devices Market Segmental Analysis & Forecast, By Procedure Type, 2022–2035, Value (USD Billion)
 7.1 Introduction
 7.2 Coiling
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022–2035
 7.3 Thrombectomy
 7.4 Stenting
 7.5 Others

8. Neurointerventional Devices Market Segmental Analysis & Forecast, By End-User, 2022–2035, Value (USD Billion)
 8.1 Introduction
 8.2 Hospitals
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022–2035
 8.3 Specialty Clinics
 8.4 Ambulatory Surgical Centers

9. Neurointerventional Devices Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
 9.1 Introduction
 9.2 North America
  9.2.1 Key Trends
  9.2.2 Neurointerventional Devices Market Size & Forecast, By Product, 2022–2035
  9.2.3 Neurointerventional Devices Market Size & Forecast, By Application, 2022–2035
  9.2.4 Neurointerventional Devices Market Size & Forecast, By Procedure Type, 2022–2035
  9.2.5 Neurointerventional Devices Market Size & Forecast, By End-User, 2022–2035
  9.2.6 Neurointerventional Devices Market Size & Forecast, By Country, 2022–2035
   9.2.6.1 US
   9.2.6.2 Canada
 9.3 Europe
  9.3.1 Key Trends
  9.3.2 Neurointerventional Devices Market Size & Forecast, By Product, 2022–2035
  9.3.3 Neurointerventional Devices Market Size & Forecast, By Application, 2022–2035
  9.3.4 Neurointerventional Devices Market Size & Forecast, By Procedure Type, 2022–2035
  9.3.5 Neurointerventional Devices Market Size & Forecast, By End-User, 2022–2035
  9.3.6 Neurointerventional Devices Market Size & Forecast, By Country, 2022–2035
   9.3.6.1 Germany
   9.3.6.2 France
   9.3.6.3 UK
   9.3.6.4 Italy
   9.3.6.5 Spain
   9.3.6.6 Poland
   9.3.6.7 Russia
   9.3.6.8 Rest of Europe
 9.4 Asia Pacific
  9.4.1 Key Trends
  9.4.2 Neurointerventional Devices Market Size & Forecast, By Product, 2022–2035
  9.4.3 Neurointerventional Devices Market Size & Forecast, By Application, 2022–2035
  9.4.4 Neurointerventional Devices Market Size & Forecast, By Procedure Type, 2022–2035
  9.4.5 Neurointerventional Devices Market Size & Forecast, By End-User, 2022–2035
  9.4.6 Neurointerventional Devices Market Size & Forecast, By Country, 2022–2035
   9.4.6.1 China
   9.4.6.2 India
   9.4.6.3 Japan
   9.4.6.4 South Korea
   9.4.6.5 Australia
   9.4.6.6 ASEAN Countries
   9.4.6.7 Rest of Asia Pacific
 9.5 Latin America
  9.5.1 Key Trends
  9.5.2 Neurointerventional Devices Market Size & Forecast, By Product, 2022–2035
  9.5.3 Neurointerventional Devices Market Size & Forecast, By Application, 2022–2035
  9.5.4 Neurointerventional Devices Market Size & Forecast, By Procedure Type, 2022–2035
  9.5.5 Neurointerventional Devices Market Size & Forecast, By End-User, 2022–2035
  9.5.6 Neurointerventional Devices Market Size & Forecast, By Country, 2022–2035
   9.5.6.1 Brazil
   9.5.6.2 Argentina
   9.5.6.3 Mexico
   9.5.6.4 Colombia
   9.5.6.5 Rest of Latin America
 9.6 Middle East & Africa
  9.6.1 Key Trends
  9.6.2 Neurointerventional Devices Market Size & Forecast, By Product, 2022–2035
  9.6.3 Neurointerventional Devices Market Size & Forecast, By Application, 2022–2035
  9.6.4 Neurointerventional Devices Market Size & Forecast, By Procedure Type, 2022–2035
  9.6.5 Neurointerventional Devices Market Size & Forecast, By End-User, 2022–2035
  9.6.6 Neurointerventional Devices Market Size & Forecast, By Country, 2022–2035
   9.6.6.1 UAE
   9.6.6.2 Saudi Arabia
   9.6.6.3 Qatar
   9.6.6.4 South Africa
   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape
 10.1 Key Players' Positioning
 10.2 Competitive Developments
  10.2.1 Year-Wise Strategies & Development, 2022–2026
 10.3 Market Share Analysis, 2025
 10.4 Product/Service & Application Benchmarking
  10.4.1 Product/Service Specifications & Features By Key Players
  10.4.2 Product/Service Heatmap By Key Players
  10.4.3 Application Heatmap By Key Players
 10.5 Industry Start-Up & Innovation Landscape
 10.6 Key Company Profiles
  10.6.1 Medtronic plc
   10.6.1.1 Company Overview & Snapshot
   10.6.1.2 Product/Service Portfolio
   10.6.1.3 Key Company Financials
   10.6.1.4 Geographical Presence
   10.6.1.5 SWOT Analysis
  10.6.2 Stryker Corporation
  10.6.3 Boston Scientific Corporation
  10.6.4 Terumo Corporation
  10.6.5 Penumbra, Inc.
  10.6.6 Johnson & Johnson MedTech (Cerenovus)
  10.6.7 MicroVention, Inc. (Terumo)
  10.6.8 Abbott Laboratories
  10.6.9 Cook Medical LLC
  10.6.10 Asahi Intecc Co., Ltd.
  10.6.11 MicroPort Scientific Corporation
  10.6.12 W. L. Gore & Associates, Inc.
  10.6.13 Wallaby Medical
  10.6.14 Zylox-Tonbridge Medical Technology Co., Ltd.
  10.6.15 Balt SA
  10.6.16 phenox GmbH
  10.6.17 Rapid Medical Ltd.
  10.6.18 Imperative Care, Inc.
  10.6.19 GE HealthCare Technologies Inc.
  10.6.20 Siemens Healthineers AG

11. Analyst Recommendations
 11.1 SNS Insider Opportunity Map
 11.2 Industry Low-Hanging Fruit Assessment
 11.3 Market Entry & Growth Strategy
 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix
 14.1 List Of Tables
 14.2 List Of Figures